化学信息学对分子子和癌细胞的洞察
Ciceron Ayala-Orozco1, Hamid Teimouri1,2, Angela Medvedeva1,2
1Department of Chemistry, Rice University, Houston, Texas 77005, United States.
Journal of chemical information and modeling
|July 3, 2024
概括
分子子提供有针对性的癌症治疗,副作用最小. 这项研究阐明了它们的微观机制,确定了改善药物设计的关键结构特征.
科学领域:
- 在瘤学瘤学.
- 药用化学 医学化学
- 生物物理学的生物物理.
背景情况:
- 开发具有最小副作用的新型癌症疗法是一个关键的医疗挑战.
- 分子是一个有前途的有机分子类别,可以选择性地准和消除癌细胞.
- 在分子子活动的基础上,精确的微观机制仍然不太清楚.
研究的目的:
- 为了阐明分子子抗癌活动的微观方面.
- 为了将物理化学性质与杀死癌细胞的能力相关联.
- 确定用于合理设计新型抗癌药物的关键结构特征.
主要方法:
- 理论分析与实验测量相结合.
- 一种整合统计分析和化学信息学的物理化学方法.
- 分子特性与对癌细胞的细胞毒性作用的相关性.
主要成果:
- 澄清了分子电作用的微观机制.
- 确定了对抗癌疗效至关重要的特定物理化学性质和结构特征.
- 提供了对子分子相互作用的见解.
结论:
- 理论分析提高了对分子杆机制的理解.
- 强调需要进一步的研究,以充分阐明杆活动.
- 强调了一个强大的物理化学框架的潜力,用于合理的药物设计.
相关概念视频
Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Cancers Originate from Somatic Mutations in a Single Cell
11.9K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
11.9K
What is Cancer?
10.6K
Cells and tissues must meticulously coordinate their activities for the normal functioning of the human body. Therefore, they exhibit socially responsible behavior - resting, growing, dividing, differentiating, or dying - for the organism’s benefit. Cancer arises when cells divide uncontrollably and invade other tissues or organs.
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of...
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of...
10.6K
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K


